Percussionaire Corporation is recalling approximately 52,983 IPV (Intrapulmonary Percussive Ventilation) therapy In-Line Valves, specifically models P5-TEE and P5-TEE-20. The recall was initiated because current labeling does not sufficiently emphasize that a blue cap on the valve must be removed before starting respiratory therapy. If the cap remains in place, it can block the delivery of air to the patient, which is a critical safety failure. Consumers should contact their healthcare provider or the manufacturer to receive updated safety instructions and labeling.
Failure to remove the blue cap from the in-line valve before starting therapy will completely block the patient's air passage. This can lead to a sudden lack of oxygen, respiratory distress, or other life-threatening medical emergencies.
Updated Labeling and Safety Instructions
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.